Dr. Andrew Francis Leuchter, MD

Dr. Leuchter practices at Resnick Neuropsychiatric Hospital at UCLA in Los Angeles, California.

Dr. Leuchter's NPI, 1518998558, was assigned on July 6, 2006. Dr. Leuchter graduated from Baylor College Of Medicine in 1980. Dr. Leuchter holds California license A37496.

Dr. Leuchter's primary practice is Resnick Neuropsychiatric Hospital at UCLA, at 150 Ucla Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 267-9308.

Dr. Leuchter's primary practice is Resnick Neuropsychiatric Hospital at UCLA in Los Angeles, California. The medical group on file is UCLA Health. Dmand AI also links Dr. Leuchter to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leuchter practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Leuchter's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Leuchter is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Leuchter's licenses on file in 2 states: California and Texas.

Dmand AI lists depression among the conditions Dr. Leuchter treats.

CMS data shows 77 Medicare services from Dr. Leuchter across 1 procedure code in 2024, for 38 Medicare patients. Medicare paid $8,721 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw Dr. Leuchter in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have depression, and 75% have mood disorders. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Leuchter's median patient age at 45, with 55% women.

In 2024, Dr. Leuchter wrote 137 Medicare Part D claims for 11 patients. 81% of them were for generic drugs. CMS names the drug for 59 of them, across 4 drugs with 11 or more claims each, at $5,659 in total drug cost. In 2023, CMS named 107 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Leuchter for performance year 2024, reported as part of a group. Dr. Leuchter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leuchter as offering telehealth.

Dmand AI links 7 papers to Dr. Leuchter, published from 2013 to 2025. Dr. Leuchter's most frequent co-authors are Ian Cook, MD, Linda L. Carpenter, MD and Brian Andrew Kobayashi, MD.

Dmand AI links Dr. Leuchter to 10 clinical trials, 5 of them phase 4 studies. Conditions studied include Depressive Disorder, Major, Depressive Disorder and Depression. University of California, Los Angeles sponsors the most, 7.

CMS Open Payments shows 6 general payments to Dr. Leuchter from 2 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 73% of the total. Abbott Laboratories paid the most, $475.

Dmand AI lists 4 awards for Dr. Leuchter, most recently America's Top Doctors in 2014.

Dr. Leuchter graduated from Baylor College Of Medicine in 1980.

Dr. Leuchter is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.